Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Brett Bade MD

Brett C. Bade MD

Northwell, New Hyde Park, New York; Institute of Health System Science, Feinstein Institutes for Medical Research, Manhasset, New York; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York

Dr. Bade is a pulmonary and critical care physician practicing in New York. His clinical and research interests are in lung cancer screening and survivorship care. Though screening has the potential to dramatically improve lung cancer mortality and survival, the current “state” of care is that few patients undergo screening, adherence to follow-up is poor, and disparities in healthcare (e.g., race, ethnicity, socioeconomic status) impair the provision of screening. Further, once diagnosed, most patients with lung cancer have chronic quality-of-life (QoL) impairments. Dr. Bade's career goal is to improve the current standard of lung cancer care by (1) identifying barriers to lung cancer screening; (2) design, test, and implement measures to address identified barriers; (3) identify predictors of impaired QoL in lung cancer survivors, and (4) design, test, and implement measures to optimize QoL.

Disclosures

Site PI for industry trials from Nucleix, Delfi Diagnostics, and Biodesix